Orolingual angioedema associated with ACE inhibitor use after rtPA treatment of acute stroke.
Rafii
Michael S
MS
Department of Neurology, The Johns Hopkins Hospital, Baltimore, MD 21287, USA.
Koenig
Matthew
M
Ziai
Wendy C
WC
D000208:Acute Disease / Q000628:therapy; D017311:Amlodipine / Q000009:adverse effects; D000799:Angioedema / Q000139:chemically induced* / Q000188:drug therapy / Q000503:physiopathology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D001552:Benzazepines / Q000009:adverse effects; D003907:Dexamethasone / Q000627:therapeutic use; D004347:Drug Interactions / Q000502:physiology; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D020244:Infarction, Middle Cerebral Artery / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009055:Mouth / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects*; D014059:Tongue / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; D001552:Benzazepines; D006633:Histamine Antagonists; D017311:Amlodipine; D003907:Dexamethasone; D010959:Tissue Plasminogen Activator; C044946:benazepril